Growth Metrics

Integra Lifesciences Holdings (IART) Retained Earnings (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Retained Earnings for 17 consecutive years, with -$30.1 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 103.2% to -$30.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$30.1 million through Dec 2025, down 103.2% year-over-year, with the annual reading at -$30.1 million for FY2025, 103.2% down from the prior year.
  • Retained Earnings hit -$30.1 million in Q4 2025 for Integra Lifesciences Holdings, down from $425.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $943.6 million in Q1 2024 to a low of -$50.0 million in Q2 2021.
  • Historically, Retained Earnings has averaged $228.3 million across 5 years, with a median of -$11.3 million in 2022.
  • Biggest five-year swings in Retained Earnings: tumbled 1512.68% in 2021 and later skyrocketed 52649.63% in 2024.
  • Year by year, Retained Earnings stood at -$45.2 million in 2021, then soared by 2046.89% to $879.1 million in 2022, then tumbled by 101.72% to -$15.1 million in 2023, then surged by 6322.13% to $939.9 million in 2024, then crashed by 103.2% to -$30.1 million in 2025.
  • Business Quant data shows Retained Earnings for IART at -$30.1 million in Q4 2025, $425.1 million in Q3 2025, and -$30.9 million in Q2 2025.